195 related articles for article (PubMed ID: 35121673)
41. Facioscapulohumeral Muscular Dystrophy: Update on Pathogenesis and Future Treatments.
Hamel J; Tawil R
Neurotherapeutics; 2018 Oct; 15(4):863-871. PubMed ID: 30361930
[TBL] [Abstract][Full Text] [Related]
42. Hemizygosity for SMCHD1 in Facioscapulohumeral Muscular Dystrophy Type 2: Consequences for 18p Deletion Syndrome.
Lemmers RJ; van den Boogaard ML; van der Vliet PJ; Donlin-Smith CM; Nations SP; Ruivenkamp CA; Heard P; Bakker B; Tapscott S; Cody JD; Tawil R; van der Maarel SM
Hum Mutat; 2015 Jul; 36(7):679-83. PubMed ID: 25820463
[TBL] [Abstract][Full Text] [Related]
43. Digenic Inheritance of Shortened Repeat Units of the D4Z4 Region and a Loss-of-Function Variant in
Cascella R; Strafella C; Caputo V; Galota RM; Errichiello V; Scutifero M; Petillo R; Marella GL; Arcangeli M; Colantoni L; Zampatti S; Ricci E; Deidda G; Politano L; Giardina E
Front Neurol; 2018; 9():1027. PubMed ID: 30546343
[TBL] [Abstract][Full Text] [Related]
44. Consequences of epigenetic derepression in facioscapulohumeral muscular dystrophy.
Greco A; Goossens R; van Engelen B; van der Maarel SM
Clin Genet; 2020 Jun; 97(6):799-814. PubMed ID: 32086799
[TBL] [Abstract][Full Text] [Related]
45. SMCHD1 mutations associated with a rare muscular dystrophy can also cause isolated arhinia and Bosma arhinia microphthalmia syndrome.
Shaw ND; Brand H; Kupchinsky ZA; Bengani H; Plummer L; Jones TI; Erdin S; Williamson KA; Rainger J; Stortchevoi A; Samocha K; Currall BB; Dunican DS; Collins RL; Willer JR; Lek A; Lek M; Nassan M; Pereira S; Kammin T; Lucente D; Silva A; Seabra CM; Chiang C; An Y; Ansari M; Rainger JK; Joss S; Smith JC; Lippincott MF; Singh SS; Patel N; Jing JW; Law JR; Ferraro N; Verloes A; Rauch A; Steindl K; Zweier M; Scheer I; Sato D; Okamoto N; Jacobsen C; Tryggestad J; Chernausek S; Schimmenti LA; Brasseur B; Cesaretti C; García-Ortiz JE; Buitrago TP; Silva OP; Hoffman JD; Mühlbauer W; Ruprecht KW; Loeys BL; Shino M; Kaindl AM; Cho CH; Morton CC; Meehan RR; van Heyningen V; Liao EC; Balasubramanian R; Hall JE; Seminara SB; Macarthur D; Moore SA; Yoshiura KI; Gusella JF; Marsh JA; Graham JM; Lin AE; Katsanis N; Jones PL; Crowley WF; Davis EE; FitzPatrick DR; Talkowski ME
Nat Genet; 2017 Feb; 49(2):238-248. PubMed ID: 28067909
[TBL] [Abstract][Full Text] [Related]
46. Different clinicopathological features between Japanese siblings with facioscapulohumeral muscular dystrophy 2 with a novel nonsense SMCHD1 mutation (Arg552
Ohta Y; Tadokoro K; Sasaki R; Takahashi Y; Sato K; Takemoto M; Hishikawa N; Shang J; Yamashita T; Takehisa Y; Nishino I; Abe K
J Clin Neurosci; 2018 Dec; 58():215-217. PubMed ID: 30327220
[TBL] [Abstract][Full Text] [Related]
47. A focal domain of extreme demethylation within D4Z4 in FSHD2.
Hartweck LM; Anderson LJ; Lemmers RJ; Dandapat A; Toso EA; Dalton JC; Tawil R; Day JW; van der Maarel SM; Kyba M
Neurology; 2013 Jan; 80(4):392-9. PubMed ID: 23284062
[TBL] [Abstract][Full Text] [Related]
48. CLIA Laboratory Testing for Facioscapulohumeral Dystrophy: A Retrospective Analysis.
Rieken A; Bossler AD; Mathews KD; Moore SA
Neurology; 2021 Feb; 96(7):e1054-e1062. PubMed ID: 33443126
[TBL] [Abstract][Full Text] [Related]
49. Role of the Chromosome Architectural Factor SMCHD1 in X-Chromosome Inactivation, Gene Regulation, and Disease in Humans.
Wang CY; Brand H; Shaw ND; Talkowski ME; Lee JT
Genetics; 2019 Oct; 213(2):685-703. PubMed ID: 31420322
[TBL] [Abstract][Full Text] [Related]
50. Methylation of the 4q35 D4Z4 repeat defines disease status in facioscapulohumeral muscular dystrophy.
Erdmann H; Scharf F; Gehling S; Benet-Pagès A; Jakubiczka S; Becker K; Seipelt M; Kleefeld F; Knop KC; Prott EC; Hiebeler M; Montagnese F; Gläser D; Vorgerd M; Hagenacker T; Walter MC; Reilich P; Neuhann T; Zenker M; Holinski-Feder E; Schoser B; Abicht A
Brain; 2023 Apr; 146(4):1388-1402. PubMed ID: 36100962
[TBL] [Abstract][Full Text] [Related]
51. Identification of variants in the 4q35 gene FAT1 in patients with a facioscapulohumeral dystrophy-like phenotype.
Puppo F; Dionnet E; Gaillard MC; Gaildrat P; Castro C; Vovan C; Bertaux K; Bernard R; Attarian S; Goto K; Nishino I; Hayashi Y; Magdinier F; Krahn M; Helmbacher F; Bartoli M; Lévy N
Hum Mutat; 2015 Apr; 36(4):443-53. PubMed ID: 25615407
[TBL] [Abstract][Full Text] [Related]
52. Remotely acting SMCHD1 gene regulatory elements: in silico prediction and identification of potential regulatory variants in patients with FSHD.
Mayes MB; Morgan T; Winston J; Buxton DS; Kamat MA; Smith D; Williams M; Martin RL; Kleinjan DA; Cooper DN; Upadhyaya M; Chuzhanova N
Hum Genomics; 2015 Oct; 9():25. PubMed ID: 26446085
[TBL] [Abstract][Full Text] [Related]
53. Genotype and phenotype analysis of 43 Iranian facioscapulohumeral muscular dystrophy patients; Evidence for anticipation.
Alavi A; Esmaeili S; Nafissi S; Kahrizi K; Najmabadi H
Neuromuscul Disord; 2018 Apr; 28(4):303-314. PubMed ID: 29402602
[TBL] [Abstract][Full Text] [Related]
54. Facioscapulohumeral Muscular Dystrophy.
Statland JM; Tawil R
Continuum (Minneap Minn); 2016 Dec; 22(6, Muscle and Neuromuscular Junction Disorders):1916-1931. PubMed ID: 27922500
[TBL] [Abstract][Full Text] [Related]
55. Dnmt3b regulates DUX4 expression in a tissue-dependent manner in transgenic D4Z4 mice.
Bouwman LF; den Hamer B; Verveer EP; Lerink LJS; Krom YD; van der Maarel SM; de Greef JC
Skelet Muscle; 2020 Oct; 10(1):27. PubMed ID: 33004076
[TBL] [Abstract][Full Text] [Related]
56. Identification of SMCHD1 domains for nuclear localization, homo-dimerization, and protein cleavage.
Hiramuki Y; Tapscott SJ
Skelet Muscle; 2018 Aug; 8(1):24. PubMed ID: 30071896
[TBL] [Abstract][Full Text] [Related]
57. DICER/AGO-dependent epigenetic silencing of D4Z4 repeats enhanced by exogenous siRNA suggests mechanisms and therapies for FSHD.
Lim JW; Snider L; Yao Z; Tawil R; Van Der Maarel SM; Rigo F; Bennett CF; Filippova GN; Tapscott SJ
Hum Mol Genet; 2015 Sep; 24(17):4817-28. PubMed ID: 26041815
[TBL] [Abstract][Full Text] [Related]
58. FSHD2- and BAMS-associated mutations confer opposing effects on SMCHD1 function.
Gurzau AD; Chen K; Xue S; Dai W; Lucet IS; Ly TTN; Reversade B; Blewitt ME; Murphy JM
J Biol Chem; 2018 Jun; 293(25):9841-9853. PubMed ID: 29748383
[TBL] [Abstract][Full Text] [Related]
59. SMCHD1 is involved in de novo methylation of the DUX4-encoding D4Z4 macrosatellite.
Dion C; Roche S; Laberthonnière C; Broucqsault N; Mariot V; Xue S; Gurzau AD; Nowak A; Gordon CT; Gaillard MC; El-Yazidi C; Thomas M; Schlupp-Robaglia A; Missirian C; Malan V; Ratbi L; Sefiani A; Wollnik B; Binetruy B; Salort Campana E; Attarian S; Bernard R; Nguyen K; Amiel J; Dumonceaux J; Murphy JM; Déjardin J; Blewitt ME; Reversade B; Robin JD; Magdinier F
Nucleic Acids Res; 2019 Apr; 47(6):2822-2839. PubMed ID: 30698748
[TBL] [Abstract][Full Text] [Related]
60. SMCHD1 and LRIF1 converge at the FSHD-associated D4Z4 repeat and LRIF1 promoter yet display different modes of action.
Šikrová D; Testa AM; Willemsen I; van den Heuvel A; Tapscott SJ; Daxinger L; Balog J; van der Maarel SM
Commun Biol; 2023 Jun; 6(1):677. PubMed ID: 37380887
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
